Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro

Critical Care Medicine

Volumn 31, Issue 4, 2003, Pages 1147-1153

  Uchiba, Mitsuhiro ^a   Okajima, Kenji ^a   Kaun, Christoph ^b   Binder, Bernd R ^b   Wojta, Johann ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute respiratory distress syndrome; Disseminated intravascular coagulation; E selectin; Gabexate mesilate; Intercellular adhesion molecule 1; Nuclear factor B

Indexed keywords

CELL DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GABEXATE MESILATE; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; L SELECTIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULATION; ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; UMBILICAL VEIN; WESTERN BLOTTING;

ANTICOAGULANTS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GABEXATE; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0037389283     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000060005.48885.2B     Document Type: Article

References (31)

1. Hasegawa N, Husari AW, Hart WT, et al: Role of the coagulation system in ARDS. Chest 1994; 105:268-277
2. Bevilacqua MP, Pober JS, Majeau GR, et al: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986; 83:4533-4537
3. Zimmerman GA, Albertine KH, Carveth HJ, et al: Endothelial activation in ARDS. Chest 1999; 116:18S-24S
4. Fox RB: Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest 1984; 74:1456-1464
5. Zimmerman BJ, Grangder DN: Reperfusion-induced leukocyte infiltration: Role of elastase. Am J Physiol 1990; 259:H390-H394
6. Hou J, Baichwal V, Cao Z: Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1994; 91:11641-11645
7. Read MA, Whitley MZ, Gupta S, et al: Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 1997; 272:2753-2761
8. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today 1998; 19:80-88
9. Madge LA, Pober JS: TNF Signaling in vascular endothelial cells. Exp Mol Pathol 2001; 70:317-325
10. van der Poll T, Coyle SM, Levi M, et al: Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 1997; 89:3727-3734
11. Mulligan MS, Varani J, Dame MK, et al: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991; 88:1396-1406
12. Tamura Y, Hirado M, Okamura K, et al: Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, Clr and Clesterase. Biochim Biophys Acta 1977; 484:417-422
13. Taenaka N, Shimada Y, Hirata T, et al: Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med 1983; 9:735-738
14. Murakami K, Okajima K, Uchiba M, et al: Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocyte. Crit Care Med 1996; 24:1047-1053
15. Okajima K, Fujise R, Motosato Y, et al: Plasma levels of granulocyte dastase-alpha 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications. Am J Hematol 1994; 47:82-88
16. Jaffe EA, Nachman RL, Becher CG, et al: Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745-2756
17. Mechtcheriakova D, Wlachos A, Holzmüller H, et al: Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 1999; 93:3811-3823
18. Stangl V, Günther C, Jarrin A, et al: Homocysteine inhibits TNF-α-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-κB dependent pathway. Biochem Biophys Res Commun 2001; 280:1093-1100
19. Uchiba M, Okajima K, Murakami K, et al: Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats. Am J Respir Crit Care Med 1997; 155:711-718
20. Whelan J, Ghersa P, van Huijsduijen RH, et al: An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial cell adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res 1991; 19:2645-2653
21. Read MA, Whitley MZ, Williams AJ, et al: NF-κB and IκB-α: An inducible regulatory system in endothelial activation. J Exp Med 1994; 179:503-512
22. Ledebeur HC, Park TP: Transcriptional regulation of the intracellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem 1995; 270:933-943
23. Kalogeris TJ, Laroux FS, Cockrell A, et al: Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells. Am J Physiol 1999; 276:C856-C864
24. Chen CC, Rosenbloom CL, Anderson DC, et al: Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation. J Immunol 1995; 155:3538-3545
25. Ohno H, Kosaki G, Kambayashi J, et al: FOY: [ethyl P-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro. Thromb Res 1980; 19:579-588
26. Nishijima MK, Takezawa J, Taenaka N, et al: Application of HPLC measurement of plasma concentration of gabexate mesilate. Thromb Res 1983; 31:279-284
27. Olson ST: Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin. J Biol Chem 1988; 263:1698-1708
28. Ridings PC, Windsor AC, Jutila MA, et al: A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 1995; 152:247-253
29. Gardinali M, Borrelli E, Chiara O, et al: Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med 2000; 161:1022-1029
30. Taoka Y, Okajima K, Uchiba M, et al: Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats. Crit Care Med 1997; 25:874-879
31. Harada N, Okajima K, Kushimoto S: Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med 1999; 27:1958-1964